Enrich Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-11-2024
- Paid Up Capital ₹ 0.45 M
as on 17-11-2024
- Company Age 14 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 17-11-2024
- Satisfied Charges ₹ 1.20 M
as on 17-11-2024
- Revenue -39.38%
(FY 2023)
- Profit -91.05%
(FY 2023)
- Ebitda -60.39%
(FY 2023)
- Net Worth 0.66%
(FY 2023)
- Total Assets 0.99%
(FY 2023)
About Enrich Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.45 M.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹1.20 M, as per Ministry of Corporate Affairs (MCA) records.
Nikunj Trivedi, Alpeshkumar Shastri, and Tapan Mistry serve as directors at the Company.
- CIN/LLPIN
U24230GJ2010PTC062425
- Company No.
062425
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2010
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- LocationVadodara, Gujarat
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Enrich Life Sciences Private Limited offer?
Enrich Life Sciences Private Limited offers a wide range of products and services, including Popular Category, Bone & Joint Care, Vitamins & Supplements, Mineral Supplements.
Who are the key members and board of directors at Enrich Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikunj Trivedi  | Director | 25-Sep-2010 | Current |
| Alpeshkumar Shastri | Director | 25-Sep-2010 | Current |
| Tapan Mistry | Director | 25-Sep-2010 | Current |
Financial Performance of Enrich Life Sciences.
Enrich Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 39.38% decrease. The company also saw a substantial fall in profitability, with a 91.05% decrease in profit. The company's net worth moved up by a moderate rise of 0.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Enrich Life Sciences?
In 2023, Enrich Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sarvam Medicare Private LimitedActive 8 years 7 monthsNikunj Trivedi and Alpeshkumar Shastri are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 25 Jan 2022 | ₹4.00 M | Open |
Others Creation Date: 26 Sep 2017 | ₹1.20 M | Satisfied |
How Many Employees Work at Enrich Life Sciences?
Unlock and access historical data on people associated with Enrich Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Enrich Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Enrich Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
